Clinical Trial Update: Rifaximin Predicts the Complications of Decompensated Cirrhosis [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating rifaximin for predicting complications in patients with decompensated cirrhosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Decompensated Cirrhosis

Drugs mentioned

• Rifaximin (rifaximin)

Snippet

Sponsor: Shanghai Changzheng Hospital | Conditions: Cirrhosis | Phase 4 | Status: UNKNOWN